FDA Drug recall D-1278-2014
Lidocaine HCl Injection, USP, 2%, 20 mg per mL, packaged in 5-mL single-dose vials, 10 vials per box, Rx Only, Hospira, Inc., Lake Forest,…
- FDA Drug
- Class I
- terminated
- Published 2014-05-07
On 2014-05-07 the FDA classified a Class I recall of Lidocaine HCl Injection, USP, 2%, 20 mg per mL, packaged in 5-mL single-dose vials, 10 vials per box, Rx Only, Hospira, Inc., Lake Forest,… by Hospira, citing presence of Particulate Matter- Confimed customer complaint of particulates embedded in glass container and in contact with product solution.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1278-2014 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2013-12-23 |
| Published | 2014-05-07 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Hospira |
| Distribution | US |
Product
Lidocaine HCl Injection, USP, 2%, 20 mg per mL, packaged in 5-mL single-dose vials, 10 vials per box, Rx Only, Hospira, Inc., Lake Forest, IL. 60045, NDC 0409-2066-05.
Reason
Presence of Particulate Matter- Confimed customer complaint of particulates embedded in glass container and in contact with product solution.
Identifiers
| ndc | 0409-2066-10 |
|---|---|
| ndc | 0409-2066-05 |
| code_info | Lot 32135DD; Exp 08/15 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1278-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.